These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2860932)

  • 1. Butaperazine pharmacokinetics in tardive dyskinesia.
    Wolf ME; Javaid JI; Mosnaim AD; Davis JM
    Biopharm Drug Dispos; 1985; 6(2):223-7. PubMed ID: 2860932
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of butaperazine and plasma methionine-enkephalin levels in schizophrenic and affective disorder patients with tardive dyskinesia.
    Mosnaim AD; Wolf ME
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):27S-30S. PubMed ID: 2906066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of butaperazine in serum.
    Davis JM; Janowsky DS; Sekerke HJ; Manier H; el-Yousef MK
    Adv Biochem Psychopharmacol; 1974; 9(0):433-43. PubMed ID: 4151767
    [No Abstract]   [Full Text] [Related]  

  • 4. Butaperazine pharmacokinetics. Effect of dosage regimen on steady state blood levels.
    Cooper TB; Simpson GM; Haher EF; Bergner PE
    Arch Gen Psychiatry; 1975 Jul; 32(7):903-5. PubMed ID: 239664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia: probing abnormal metabolism with promethazine.
    Bates GD; Lopes O; van Woerkom AE; Klovrza L; Waring R
    Acta Psychiatr Scand; 1999 Apr; 99(4):294-9. PubMed ID: 10223433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of GABA-energic system in the central nervous system in clinical psychologic medicine].
    Ciu Z; Gao BL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Aug; 23(4):249-51. PubMed ID: 2253516
    [No Abstract]   [Full Text] [Related]  

  • 7. Free radical mechanisms in schizophrenia and tardive dyskinesia.
    Cadet JL; Kahler LA
    Neurosci Biobehav Rev; 1994; 18(4):457-67. PubMed ID: 7708360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ethmozin pharmacokinetics after a single intravenous administration].
    Piotrovskiĭ VK; Merkulova IN; Romina NN; Metelitsa VI
    Kardiologiia; 1982 May; 22(5):75-80. PubMed ID: 7047858
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors.
    Kolbe H; Clow A; Jenner P; Marsden CD
    Neurology; 1981 Apr; 31(4):434-9. PubMed ID: 6111766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of gamma-linolenic acid in the treatment of schizophrenia and tardive dyskinesia.
    Vaddadi KS
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):67-70. PubMed ID: 1321448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butaperazine dimaleate metabolism.
    Bruce RB; Turnbull LB; Newman JH; Kinzie JM; Morris PH; Pinchbeck FM
    Xenobiotica; 1974 Apr; 4(4):197-207. PubMed ID: 4152571
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
    Seeman P
    Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions.
    Garver DL; Davis JM; Dekirmenjian H; Jones FD; Casper R; Haraszti J
    Arch Gen Psychiatry; 1976 Jul; 33(7):862-6. PubMed ID: 8025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signs of striatal dopamine transporter density increase in association with improvement of tardive dyskinesia in a patient with schizophrenia, as demonstrated by a DAT scan.
    Rizos EN; Chatziioannou S; Douzenis A; Siafakas N; Katsantoni E; Nikolaidou P; Papathanasiou M; Lykouras L
    Eur Neuropsychopharmacol; 2010 Feb; 20(2):132-6. PubMed ID: 19740630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia in outpatient schizophrenics treated with depot phenothiazines.
    Williams R; Naya A; Dalby JT
    J Clin Psychopharmacol; 1986 Oct; 6(5):318-9. PubMed ID: 3771819
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endorphins in psychiatry].
    Lajeunesse C; Villeneuve A
    Sem Hop; 1982 Dec; 58(44):2581-7. PubMed ID: 6297051
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients.
    Smith RC; Crayton J; Dekirmenjian H; Klass D; Davis JM
    Arch Gen Psychiatry; 1979 May; 36(5):579-84. PubMed ID: 35115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tardive akathisia and tardive dyskinesia].
    Fennig S; Helben J; Neumann M
    Harefuah; 1991 Jan; 120(2):71-2. PubMed ID: 1672523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia and substrates of energy metabolism in CSF.
    Goff DC; Tsai G; Beal MF; Coyle JT
    Am J Psychiatry; 1995 Dec; 152(12):1730-6. PubMed ID: 8526238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.